Skip to content
Industrial Relations, Medical Health Aged Care

QUARTERLY REPORT SHOWS BED BLOCK CRISIS CONTINUES: PARAMEDICS DIRE WARNINGS OF A DIFFICULT WINTER AHEAD

Australian Paramedics Association 2 mins read

The latest Bureau of Health Information Quarterly data shows that patients are continuing to suffer due to ongoing ramping. Paramedics say they fear the worst is yet to come. 

The latest numbers from the Bureau of Health Information’s Healthcare Quarterly Report showed bed block continuing to worsen in January-March 2023, revealing that more than one in five patients is waiting too long to be transferred into hospital care. One in ten patients in urban areas are waiting longer than 1 hour to be transferred.

APA (NSW) President Chris Kastelan said “These sobering numbers once again highlight that we desperately need action on the recommendations that came from the Inquiry into Ramping.”

“We’re about to head into flu season, where we see our system even further overloaded every year. We are really concerned for our patients and for ourselves. Standing outside a hospital in a car park in the middle of winter for 5, 6 hours gets very cold. When it rains, some hospitals don’t even have adequate shelter for us or our patients.” 

The NSW Legislative Council’s Ramping Inquiry report was released in December 2022, and exposed glaring issues with the emergency healthcare system. The report provided twelve recommendations to address the issue of bed block, including the abolishment of the wages cap, more Paramedic specialists, and the relatively simple change of implementing mobile work trailers so Paramedics can have a safe space out of the elements when stuck in bed block. 

“The Minns Government was elected with the promise of supporting health workers, but has failed to implement even one of the recommendations,” continued Mr Kastelan.

Contact:  Catherine Treloar (Organiser) 0432 415 303


Key Facts:

1 in 5 patients are waiting too long to be transferred to hospital care. 

1 in 10 metropolitan patients are waiting over an hour to be transferred. 

The Government has not actioned the ramping inquiry: https://www.parliament.nsw.gov.au/committees/inquiries/Pages/inquiry-details.aspx?pk=2892#tab-reportsandgovernmentresponses 


Contact details:

Catherine Treloar (Organiser) 0432 415 303

More from this category

  • Medical Health Aged Care
  • 13/09/2024
  • 12:40
Zenas BioPharma

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. All of the shares are being offered by Zenas. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $225.0 million. Zenas’ common stock is expected to begin trading…

  • Medical Health Aged Care
  • 13/09/2024
  • 12:31
Dementia Australia

New report reinforces dementia as chronic disease of 21st century

Updates to the Dementia in Australia report, released today by the Australian Institute of Health and Welfare (AIHW), reinforce that dementia is an urgent public health issue. Dementia is the second leading cause of death in Australia, the leading cause of death of women, the second leading cause of disease burden overall, and the leading cause of burden for people aged 65 and over. Dementia Australia CEO Professor Tanya Buchanan saidthe report highlights the enormity and impact of dementia in Australia as the chronic disease of the 21st century. “Despite the growing number of Australians diagnosed with dementia – there…

  • Medical Health Aged Care, Science
  • 13/09/2024
  • 11:08
La Trobe University

Centre to play key role in global AI medical research

Artificial intelligence promises to unlock new cures for cancer and other diseases by revolutionising the speed, cost and availability of personally designed drugs and enabling these to be tested on “digital twins" before being given to patients. AI will enable broad-spectrum like chemotherapy to be replaced by these more personalised, better targeted treatments. Scientists at La Trobe University's new Australian Centre for Artificial Intelligence in Medical Innovation (ACAMI), launched today, will also apply AI techniques to mRNA therapy development to enable faster design of more precise and effective treatments. Vice-Chancellor Professor Theo Farrell said ACAMI would sit within La Trobe’s…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.